Literature DB >> 27207130

Lower-extremity complications with femoral extracorporeal life support.

Prashanth Vallabhajosyula1, Matthew Kramer2, Sofiane Lazar2, Fenton McCarthy2, Eduardo Rame3, Joyce Wald3, Wilson Szeto2, Matthew Williams2, Pavan Atluri2, Nimesh Desai2, Michael Acker2.   

Abstract

OBJECTIVE: Patients undergoing emergency peripheral arteriovenous extracorporeal life support were evaluated for lower-extremity complications on the basis of the ipsilateral limb perfusion strategy.
METHODS: In a retrospective review of patients receiving extracorporeal life support (2008-2013), 105 of 250 underwent femoral extracorporeal life support. For ipsilateral lower-extremity perfusion, patients underwent no superficial femoral artery cannulation (n = 35), percutaneous superficial femoral artery cannulation (n = 23), or open superficial femoral artery cannulation (n = 47).
RESULTS: Patients' mean age was 50 ± 16 years, and 63% (n = 67) were male. A total of 92 patients (88%) had primary cardiac emergency, and 13 patients (12%) had cardiopulmonary emergency. The 30-day in-hospital mortality was 65% (n = 68), with an overall lower-extremity complication rate of 13% (n = 14). Lower-extremity complications were highest in the percutaneous superficial femoral artery (n = 6, 26%) and no superficial femoral artery (n = 7, 20%) groups (n = 1 [2%] in open superficial femoral artery group). In 2 group comparisons, the open superficial femoral artery group had significantly lower lower-extremity complications than the no superficial femoral artery (P = .02) and percutaneous superficial femoral artery (P = .004) groups. There was no difference between the no superficial femoral artery and percutaneous superficial femoral artery groups (P = .7). In the no superficial femoral artery group, emergency thromboembolectomy (n = 2), fasciotomy (n = 3), and emergency superficial femoral artery cannula placement (n = 2) were required. In the percutaneous superficial femoral artery group, thromboembolectomy with superficial femoral artery repair (n = 2), fasciotomy (n = 1), below-knee amputation (n = 1), open superficial femoral artery cannula revision (n = 1), and loss of distal signals from multiorgan failure (n = 1) were noted. In the open superficial femoral artery group, 1 patient had loss of signals from multiorgan failure.
CONCLUSIONS: No superficial femoral artery perfusion strategy is associated with a high lower-extremity complication rate. If percutaneous cannulation is performed, then angiographic confirmation of superficial femoral artery run-off is highly recommended. The open superficial femoral artery approach remains a safe alternative to the other strategies.
Copyright © 2016 The American Association for Thoracic Surgery. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2016        PMID: 27207130     DOI: 10.1016/j.jtcvs.2015.11.044

Source DB:  PubMed          Journal:  J Thorac Cardiovasc Surg        ISSN: 0022-5223            Impact factor:   5.209


  4 in total

1.  High rate of arterial complications in patients supported with extracorporeal life support for drug intoxication-induced refractory cardiogenic shock or cardiac arrest.

Authors:  Matteo Pozzi; Catherine Koffel; Camelia Djaref; Daniel Grinberg; Jean Luc Fellahi; Elisabeth Hugon-Vallet; Cyril Prieur; Jacques Robin; Jean François Obadia
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  Vascular access complications in patients undergoing veno-arterial ecmo and their impact on survival in patients with refractory cardiogenic shock: A retrospective 8-year study.

Authors:  Vikrampal Singh; Gurmeet Singh; Rajesh Chand Arya; Samir Kapoor; Arun Garg; Sarju Ralhan; Vivek K Gupta; Bishav Mohan; Gurpreet Singh Wander; Rajiv K Gupta
Journal:  Ann Card Anaesth       Date:  2022 Apr-Jun

Review 3.  Extracorporeal Membrane Oxygenation (ECMO) and the Critical Cardiac Patient.

Authors:  David A Baran
Journal:  Curr Transplant Rep       Date:  2017-07-10

Review 4.  Limb ischemia in peripheral veno-arterial extracorporeal membrane oxygenation: a narrative review of incidence, prevention, monitoring, and treatment.

Authors:  Eleonora Bonicolini; Gennaro Martucci; Jorik Simons; Giuseppe M Raffa; Cristina Spina; Valeria Lo Coco; Antonio Arcadipane; Michele Pilato; Roberto Lorusso
Journal:  Crit Care       Date:  2019-07-30       Impact factor: 9.097

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.